IOT-038

N/A

Report date: 2023/08/24 17:33:35
NME

Base Information

Drug NameIOT-038
Drug Alias NameIOT-038
ClassificationSmall molecules
Mechanisms of ActionFructokinases inhibitors
TargetsFructokinases
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInorbit Therapeutics AB
China Registration ClassN/A

Develop Information

Active CompaniesInorbit Therapeutics AB
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A